| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mothers | 9 | 2022 | 172 | 4.290 |
Why?
|
| Milk, Human | 10 | 2022 | 147 | 3.900 |
Why?
|
| Breast Feeding | 12 | 2022 | 159 | 3.320 |
Why?
|
| Lactation | 6 | 2022 | 110 | 2.360 |
Why?
|
| Varicose Ulcer | 8 | 2022 | 42 | 2.350 |
Why?
|
| Electroconvulsive Therapy | 27 | 2022 | 402 | 2.250 |
Why?
|
| Infant, Premature | 11 | 2022 | 284 | 2.070 |
Why?
|
| Telemedicine | 11 | 2021 | 699 | 1.580 |
Why?
|
| Infant, Very Low Birth Weight | 7 | 2021 | 69 | 1.390 |
Why?
|
| Female | 107 | 2022 | 38015 | 1.320 |
Why?
|
| Infant, Newborn | 18 | 2022 | 2453 | 1.270 |
Why?
|
| Humans | 140 | 2022 | 68525 | 1.240 |
Why?
|
| Leg Ulcer | 5 | 2021 | 26 | 1.160 |
Why?
|
| Anemia, Sickle Cell | 8 | 2022 | 364 | 1.150 |
Why?
|
| Leg | 6 | 2022 | 191 | 1.150 |
Why?
|
| Self-Management | 6 | 2022 | 82 | 1.020 |
Why?
|
| Depressive Disorder, Major | 12 | 2021 | 438 | 1.010 |
Why?
|
| Infant Nutritional Physiological Phenomena | 3 | 2021 | 72 | 0.970 |
Why?
|
| Sexual and Gender Minorities | 3 | 2020 | 37 | 0.970 |
Why?
|
| Intensive Care Units, Neonatal | 7 | 2022 | 113 | 0.960 |
Why?
|
| Self Care | 5 | 2021 | 252 | 0.950 |
Why?
|
| Male | 88 | 2021 | 37281 | 0.930 |
Why?
|
| Middle Aged | 69 | 2021 | 21119 | 0.930 |
Why?
|
| Aged | 57 | 2021 | 14842 | 0.920 |
Why?
|
| Mobile Applications | 6 | 2021 | 138 | 0.900 |
Why?
|
| Venlafaxine Hydrochloride | 7 | 2021 | 42 | 0.870 |
Why?
|
| Quality of Life | 11 | 2021 | 1515 | 0.860 |
Why?
|
| Adult | 55 | 2021 | 21375 | 0.830 |
Why?
|
| Feasibility Studies | 14 | 2021 | 652 | 0.820 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2021 | 9 | 0.800 |
Why?
|
| Infant | 13 | 2022 | 2891 | 0.790 |
Why?
|
| Social Support | 5 | 2021 | 423 | 0.790 |
Why?
|
| Depressive Disorder | 11 | 2018 | 621 | 0.780 |
Why?
|
| Models, Statistical | 2 | 2020 | 446 | 0.770 |
Why?
|
| Parenting | 3 | 2018 | 91 | 0.770 |
Why?
|
| Exercise | 5 | 2022 | 657 | 0.760 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2018 | 1085 | 0.750 |
Why?
|
| Patient Education as Topic | 4 | 2021 | 424 | 0.740 |
Why?
|
| Surveys and Questionnaires | 22 | 2021 | 2798 | 0.720 |
Why?
|
| Aged, 80 and over | 26 | 2021 | 4843 | 0.710 |
Why?
|
| Epilepsy | 6 | 2021 | 336 | 0.710 |
Why?
|
| Early Detection of Cancer | 3 | 2020 | 439 | 0.710 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 207 | 0.700 |
Why?
|
| Peripheral Arterial Disease | 2 | 2018 | 83 | 0.670 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 378 | 0.670 |
Why?
|
| Wounds and Injuries | 3 | 2018 | 334 | 0.650 |
Why?
|
| Pilot Projects | 10 | 2022 | 1341 | 0.640 |
Why?
|
| Depression | 9 | 2020 | 942 | 0.640 |
Why?
|
| Cryotherapy | 5 | 2018 | 36 | 0.620 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 283 | 0.610 |
Why?
|
| Research Design | 3 | 2019 | 729 | 0.610 |
Why?
|
| Exercise Therapy | 2 | 2020 | 183 | 0.600 |
Why?
|
| Parents | 2 | 2017 | 309 | 0.600 |
Why?
|
| Psychometrics | 7 | 2020 | 514 | 0.600 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2021 | 99 | 0.570 |
Why?
|
| Patient Discharge | 1 | 2018 | 294 | 0.550 |
Why?
|
| Foot | 3 | 2021 | 66 | 0.550 |
Why?
|
| Breast Milk Expression | 1 | 2015 | 4 | 0.520 |
Why?
|
| Nurses, Community Health | 1 | 2015 | 6 | 0.520 |
Why?
|
| Nursing Research | 3 | 2019 | 40 | 0.510 |
Why?
|
| Parenteral Nutrition | 1 | 2015 | 39 | 0.510 |
Why?
|
| Chronic Disease | 13 | 2019 | 1329 | 0.510 |
Why?
|
| Shoulder Pain | 1 | 2014 | 12 | 0.500 |
Why?
|
| Fluid Therapy | 1 | 2015 | 59 | 0.500 |
Why?
|
| Rural Population | 5 | 2018 | 397 | 0.490 |
Why?
|
| Patient Selection | 1 | 2018 | 592 | 0.480 |
Why?
|
| Chronic Pain | 1 | 2015 | 110 | 0.480 |
Why?
|
| Terminal Care | 1 | 2015 | 92 | 0.470 |
Why?
|
| Ventilator Weaning | 2 | 2004 | 27 | 0.470 |
Why?
|
| Physical Therapy Modalities | 1 | 2014 | 133 | 0.460 |
Why?
|
| Infant Formula | 2 | 2012 | 24 | 0.460 |
Why?
|
| Data Interpretation, Statistical | 3 | 2019 | 329 | 0.460 |
Why?
|
| Health Personnel | 5 | 2022 | 286 | 0.450 |
Why?
|
| Antidepressive Agents | 6 | 2018 | 216 | 0.450 |
Why?
|
| Wound Healing | 4 | 2021 | 260 | 0.440 |
Why?
|
| Disability Evaluation | 1 | 2014 | 298 | 0.430 |
Why?
|
| Health Behavior | 4 | 2019 | 458 | 0.420 |
Why?
|
| Skin Temperature | 2 | 2011 | 24 | 0.420 |
Why?
|
| Mass Screening | 5 | 2021 | 837 | 0.410 |
Why?
|
| Hospital Costs | 1 | 2012 | 117 | 0.410 |
Why?
|
| Psychiatric Status Rating Scales | 10 | 2018 | 782 | 0.410 |
Why?
|
| HIV Infections | 1 | 2019 | 775 | 0.410 |
Why?
|
| Substance-Related Disorders | 2 | 2018 | 1241 | 0.400 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2020 | 503 | 0.400 |
Why?
|
| Blood Pressure | 4 | 2021 | 1447 | 0.400 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 445 | 0.390 |
Why?
|
| South Carolina | 12 | 2021 | 2750 | 0.390 |
Why?
|
| Infrared Rays | 1 | 2011 | 12 | 0.390 |
Why?
|
| Cognition | 5 | 2021 | 512 | 0.390 |
Why?
|
| Thermometers | 1 | 2011 | 13 | 0.390 |
Why?
|
| Prospective Studies | 10 | 2021 | 3702 | 0.390 |
Why?
|
| Gestational Age | 4 | 2020 | 389 | 0.380 |
Why?
|
| Internet | 6 | 2016 | 390 | 0.370 |
Why?
|
| Foot Ulcer | 2 | 2003 | 2 | 0.370 |
Why?
|
| Stroke | 5 | 2021 | 2161 | 0.370 |
Why?
|
| Child | 16 | 2022 | 6400 | 0.360 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 1533 | 0.360 |
Why?
|
| Treatment Outcome | 21 | 2022 | 7028 | 0.360 |
Why?
|
| Clinical Competence | 1 | 2015 | 657 | 0.350 |
Why?
|
| Southeastern United States | 6 | 2021 | 281 | 0.350 |
Why?
|
| Pain | 4 | 2022 | 472 | 0.350 |
Why?
|
| Adolescent | 20 | 2021 | 8903 | 0.350 |
Why?
|
| Diabetes Mellitus | 3 | 2022 | 693 | 0.340 |
Why?
|
| Veterans | 5 | 2020 | 904 | 0.340 |
Why?
|
| Length of Stay | 1 | 2012 | 780 | 0.340 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 204 | 0.330 |
Why?
|
| Self Efficacy | 3 | 2018 | 199 | 0.330 |
Why?
|
| Caregivers | 6 | 2022 | 365 | 0.330 |
Why?
|
| Cross-Sectional Studies | 8 | 2020 | 2264 | 0.330 |
Why?
|
| Neoplasms | 1 | 2020 | 1660 | 0.330 |
Why?
|
| Cognitive Dysfunction | 3 | 2020 | 176 | 0.310 |
Why?
|
| Respiration, Artificial | 2 | 2006 | 190 | 0.310 |
Why?
|
| Feeding Behavior | 3 | 2020 | 224 | 0.300 |
Why?
|
| Retrospective Studies | 13 | 2021 | 7264 | 0.300 |
Why?
|
| Mental Health | 2 | 2016 | 278 | 0.300 |
Why?
|
| Risk Factors | 10 | 2021 | 5719 | 0.300 |
Why?
|
| Severity of Illness Index | 8 | 2018 | 1851 | 0.290 |
Why?
|
| Seizures | 5 | 2019 | 279 | 0.290 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2021 | 766 | 0.280 |
Why?
|
| Expert Systems | 1 | 2006 | 9 | 0.280 |
Why?
|
| Kangaroo-Mother Care Method | 2 | 2018 | 9 | 0.280 |
Why?
|
| Social Determinants of Health | 2 | 2018 | 96 | 0.280 |
Why?
|
| Risk Management | 1 | 2006 | 37 | 0.280 |
Why?
|
| Reproducibility of Results | 7 | 2020 | 2077 | 0.280 |
Why?
|
| Health Status Disparities | 3 | 2018 | 326 | 0.270 |
Why?
|
| Lithium Compounds | 3 | 2017 | 15 | 0.270 |
Why?
|
| Prehypertension | 2 | 2018 | 39 | 0.270 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 938 | 0.270 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2006 | 46 | 0.270 |
Why?
|
| Sex Offenses | 1 | 2008 | 170 | 0.270 |
Why?
|
| Recurrence | 5 | 2021 | 948 | 0.260 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2006 | 88 | 0.260 |
Why?
|
| Venous Insufficiency | 2 | 2018 | 27 | 0.260 |
Why?
|
| Poverty | 2 | 2016 | 218 | 0.250 |
Why?
|
| Kidney Transplantation | 3 | 2021 | 839 | 0.250 |
Why?
|
| Anxiety | 4 | 2021 | 422 | 0.250 |
Why?
|
| Cell Phone | 3 | 2016 | 43 | 0.250 |
Why?
|
| Nursing Homes | 2 | 2015 | 54 | 0.250 |
Why?
|
| Erythrocyte Transfusion | 2 | 2022 | 72 | 0.250 |
Why?
|
| Pain Management | 2 | 2018 | 186 | 0.240 |
Why?
|
| Health Promotion | 3 | 2017 | 407 | 0.240 |
Why?
|
| Waiting Lists | 2 | 2021 | 104 | 0.240 |
Why?
|
| Public Housing | 2 | 2014 | 12 | 0.240 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2016 | 285 | 0.240 |
Why?
|
| Nortriptyline | 5 | 2010 | 28 | 0.240 |
Why?
|
| Social Isolation | 2 | 2021 | 40 | 0.230 |
Why?
|
| Intubation, Intratracheal | 1 | 2004 | 99 | 0.230 |
Why?
|
| Secondary Prevention | 3 | 2021 | 291 | 0.230 |
Why?
|
| Cohort Studies | 6 | 2018 | 2356 | 0.230 |
Why?
|
| Physical Exertion | 1 | 2003 | 75 | 0.230 |
Why?
|
| Patient Admission | 2 | 2014 | 99 | 0.230 |
Why?
|
| Community-Based Participatory Research | 2 | 2016 | 133 | 0.230 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2003 | 18 | 0.230 |
Why?
|
| Medication Adherence | 3 | 2021 | 335 | 0.220 |
Why?
|
| Smoking Cessation | 3 | 2018 | 1032 | 0.220 |
Why?
|
| Living Donors | 2 | 2021 | 160 | 0.220 |
Why?
|
| United States | 13 | 2022 | 7335 | 0.210 |
Why?
|
| Gait | 1 | 2003 | 119 | 0.210 |
Why?
|
| Combined Modality Therapy | 8 | 2019 | 951 | 0.210 |
Why?
|
| Neuroimaging | 2 | 2020 | 122 | 0.210 |
Why?
|
| Diabetic Foot | 1 | 2022 | 33 | 0.210 |
Why?
|
| Lithium | 3 | 2021 | 76 | 0.210 |
Why?
|
| Time Factors | 8 | 2021 | 4655 | 0.210 |
Why?
|
| Smartphone | 2 | 2021 | 69 | 0.200 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 1054 | 0.200 |
Why?
|
| Cross Infection | 2 | 2013 | 195 | 0.200 |
Why?
|
| Child, Preschool | 8 | 2021 | 3185 | 0.200 |
Why?
|
| Publishing | 2 | 2019 | 89 | 0.200 |
Why?
|
| Safety-net Providers | 1 | 2021 | 20 | 0.200 |
Why?
|
| Young Adult | 12 | 2021 | 5708 | 0.200 |
Why?
|
| Adaptation, Psychological | 2 | 2015 | 447 | 0.200 |
Why?
|
| Nurses, Neonatal | 1 | 2020 | 3 | 0.200 |
Why?
|
| Loneliness | 1 | 2021 | 20 | 0.200 |
Why?
|
| Attitude to Health | 4 | 2018 | 403 | 0.190 |
Why?
|
| Postpartum Period | 1 | 2021 | 67 | 0.190 |
Why?
|
| Concept Formation | 1 | 2020 | 16 | 0.190 |
Why?
|
| Skin | 2 | 2016 | 451 | 0.190 |
Why?
|
| Family Health | 1 | 2021 | 83 | 0.190 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2020 | 27 | 0.190 |
Why?
|
| Schools, Nursing | 1 | 2020 | 19 | 0.190 |
Why?
|
| Organizational Innovation | 1 | 2020 | 55 | 0.190 |
Why?
|
| Cholinergic Antagonists | 1 | 2020 | 17 | 0.190 |
Why?
|
| Incidence | 3 | 2021 | 1582 | 0.180 |
Why?
|
| Health Status | 2 | 2020 | 429 | 0.180 |
Why?
|
| Combat Disorders | 1 | 2020 | 102 | 0.180 |
Why?
|
| Frailty | 1 | 2020 | 34 | 0.180 |
Why?
|
| Pain Measurement | 3 | 2017 | 328 | 0.180 |
Why?
|
| Demography | 1 | 2020 | 279 | 0.180 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 23 | 0.180 |
Why?
|
| Education, Nursing | 1 | 2020 | 55 | 0.180 |
Why?
|
| Infection Control | 1 | 2020 | 101 | 0.180 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 142 | 0.170 |
Why?
|
| Patient Compliance | 3 | 2017 | 402 | 0.170 |
Why?
|
| Pregnancy | 2 | 2022 | 2331 | 0.170 |
Why?
|
| Behavior | 1 | 2019 | 59 | 0.170 |
Why?
|
| Hypertension | 2 | 2021 | 1531 | 0.170 |
Why?
|
| Blood Transfusion | 1 | 2020 | 205 | 0.170 |
Why?
|
| Primary Prevention | 1 | 2020 | 115 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 189 | 0.170 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 122 | 0.170 |
Why?
|
| Aromatherapy | 1 | 2018 | 4 | 0.170 |
Why?
|
| Nursing Process | 1 | 2018 | 7 | 0.170 |
Why?
|
| Postthrombotic Syndrome | 1 | 2018 | 6 | 0.170 |
Why?
|
| Problem Behavior | 1 | 2018 | 20 | 0.160 |
Why?
|
| Fatigue | 1 | 2019 | 132 | 0.160 |
Why?
|
| Professionalism | 1 | 2018 | 28 | 0.160 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2018 | 91 | 0.160 |
Why?
|
| Tobacco Use Cessation | 1 | 2018 | 44 | 0.160 |
Why?
|
| Motivational Interviewing | 1 | 2018 | 40 | 0.160 |
Why?
|
| Neuropsychological Tests | 6 | 2019 | 517 | 0.160 |
Why?
|
| Meditation | 1 | 2018 | 33 | 0.160 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 87 | 0.160 |
Why?
|
| Stress, Psychological | 2 | 2014 | 824 | 0.160 |
Why?
|
| Hospital Administration | 1 | 2018 | 43 | 0.160 |
Why?
|
| Emergency Service, Hospital | 2 | 2014 | 711 | 0.160 |
Why?
|
| Hypothermia, Induced | 1 | 2018 | 93 | 0.150 |
Why?
|
| Breast | 1 | 2018 | 137 | 0.150 |
Why?
|
| Evaluation Studies as Topic | 1 | 2017 | 219 | 0.150 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 148 | 0.150 |
Why?
|
| Self Administration | 2 | 2018 | 419 | 0.150 |
Why?
|
| Disabled Persons | 1 | 2018 | 94 | 0.150 |
Why?
|
| Anticonvulsants | 1 | 2019 | 223 | 0.150 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 37 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 143 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 154 | 0.150 |
Why?
|
| Neurologic Examination | 1 | 2017 | 107 | 0.150 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 146 | 0.150 |
Why?
|
| Range of Motion, Articular | 2 | 2014 | 139 | 0.150 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2018 | 257 | 0.150 |
Why?
|
| Plant Preparations | 1 | 2017 | 18 | 0.150 |
Why?
|
| Socioeconomic Factors | 5 | 2019 | 955 | 0.150 |
Why?
|
| Dermatologic Agents | 1 | 2017 | 32 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 563 | 0.150 |
Why?
|
| Neural Pathways | 1 | 2018 | 323 | 0.140 |
Why?
|
| Compression Bandages | 1 | 2016 | 6 | 0.140 |
Why?
|
| Survivors | 2 | 2018 | 254 | 0.140 |
Why?
|
| Transsexualism | 1 | 2016 | 4 | 0.140 |
Why?
|
| Pandemics | 1 | 2020 | 346 | 0.140 |
Why?
|
| Pressure Ulcer | 1 | 2017 | 40 | 0.140 |
Why?
|
| Blood Circulation | 1 | 2016 | 18 | 0.140 |
Why?
|
| Homosexuality, Female | 1 | 2016 | 9 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2018 | 275 | 0.140 |
Why?
|
| Bisexuality | 1 | 2016 | 18 | 0.140 |
Why?
|
| Child Development | 1 | 2017 | 102 | 0.140 |
Why?
|
| Infant Health | 1 | 2016 | 5 | 0.140 |
Why?
|
| Tobacco Use Disorder | 2 | 2018 | 432 | 0.140 |
Why?
|
| Telecommunications | 1 | 2016 | 31 | 0.140 |
Why?
|
| Postnatal Care | 1 | 2016 | 16 | 0.140 |
Why?
|
| Age Factors | 3 | 2016 | 1860 | 0.140 |
Why?
|
| Prevalence | 3 | 2018 | 1609 | 0.140 |
Why?
|
| Insurance Coverage | 1 | 2016 | 99 | 0.140 |
Why?
|
| Malnutrition | 1 | 2016 | 28 | 0.140 |
Why?
|
| Cause of Death | 1 | 2016 | 241 | 0.140 |
Why?
|
| Plant Extracts | 1 | 2017 | 122 | 0.140 |
Why?
|
| Dementia | 2 | 2015 | 158 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2018 | 346 | 0.130 |
Why?
|
| Qualitative Research | 4 | 2019 | 368 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2018 | 267 | 0.130 |
Why?
|
| Nursing Staff | 1 | 2015 | 30 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2016 | 112 | 0.130 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1995 | 37 | 0.130 |
Why?
|
| Prognosis | 4 | 2021 | 2093 | 0.130 |
Why?
|
| Crime | 1 | 2014 | 53 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2020 | 659 | 0.130 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1995 | 50 | 0.130 |
Why?
|
| ROC Curve | 3 | 2017 | 392 | 0.120 |
Why?
|
| Memory Disorders | 2 | 2018 | 111 | 0.120 |
Why?
|
| Palliative Care | 1 | 2017 | 271 | 0.120 |
Why?
|
| Salivary alpha-Amylases | 1 | 2014 | 4 | 0.120 |
Why?
|
| Muscle Strength | 1 | 2014 | 62 | 0.120 |
Why?
|
| Ostomy | 1 | 2014 | 7 | 0.120 |
Why?
|
| Home Care Services | 1 | 2015 | 84 | 0.120 |
Why?
|
| Hand Strength | 1 | 2014 | 47 | 0.120 |
Why?
|
| Weight Loss | 1 | 2016 | 319 | 0.120 |
Why?
|
| Yoga | 1 | 2014 | 18 | 0.120 |
Why?
|
| Mental Competency | 1 | 2014 | 29 | 0.120 |
Why?
|
| Urinary Catheterization | 1 | 2013 | 27 | 0.120 |
Why?
|
| Guideline Adherence | 1 | 2016 | 284 | 0.120 |
Why?
|
| Hospitals | 1 | 2016 | 265 | 0.120 |
Why?
|
| Life Style | 1 | 2016 | 338 | 0.120 |
Why?
|
| Evidence-Based Nursing | 1 | 2013 | 27 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 581 | 0.120 |
Why?
|
| Upper Extremity | 1 | 2014 | 112 | 0.120 |
Why?
|
| Social Environment | 1 | 2014 | 182 | 0.110 |
Why?
|
| Teaching | 1 | 2015 | 169 | 0.110 |
Why?
|
| Time Management | 1 | 2013 | 12 | 0.110 |
Why?
|
| Transients and Migrants | 1 | 2013 | 22 | 0.110 |
Why?
|
| Remission Induction | 5 | 2016 | 111 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 772 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2013 | 71 | 0.110 |
Why?
|
| Symptom Assessment | 1 | 2013 | 33 | 0.110 |
Why?
|
| Informed Consent | 1 | 2014 | 127 | 0.110 |
Why?
|
| Drug Resistance | 3 | 2009 | 223 | 0.110 |
Why?
|
| Hydrocortisone | 1 | 2014 | 291 | 0.110 |
Why?
|
| Monitoring, Ambulatory | 1 | 2013 | 84 | 0.110 |
Why?
|
| Georgia | 3 | 2018 | 161 | 0.110 |
Why?
|
| Logistic Models | 3 | 2018 | 1419 | 0.100 |
Why?
|
| Lithium Carbonate | 2 | 2009 | 31 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 3256 | 0.100 |
Why?
|
| Time-to-Treatment | 1 | 2013 | 117 | 0.100 |
Why?
|
| Decision Making | 2 | 2006 | 410 | 0.100 |
Why?
|
| Patient Safety | 1 | 2013 | 202 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2016 | 714 | 0.100 |
Why?
|
| Obesity | 2 | 2016 | 1074 | 0.100 |
Why?
|
| Birth Weight | 2 | 2017 | 186 | 0.100 |
Why?
|
| Tobacco | 1 | 2012 | 161 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 497 | 0.100 |
Why?
|
| Microcirculation | 1 | 2011 | 77 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 85 | 0.100 |
Why?
|
| Acetylglucosamine | 1 | 2011 | 46 | 0.100 |
Why?
|
| Nurse Clinicians | 1 | 2010 | 20 | 0.100 |
Why?
|
| Brachial Artery | 1 | 2010 | 34 | 0.090 |
Why?
|
| Toes | 1 | 2010 | 27 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2011 | 94 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2014 | 310 | 0.090 |
Why?
|
| Cognition Disorders | 2 | 2010 | 342 | 0.090 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 1506 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 1465 | 0.090 |
Why?
|
| Drinking | 1 | 2009 | 35 | 0.090 |
Why?
|
| Casts, Surgical | 1 | 1989 | 13 | 0.090 |
Why?
|
| Hypoglycemic Agents | 2 | 2010 | 361 | 0.090 |
Why?
|
| Foot Diseases | 1 | 1989 | 20 | 0.090 |
Why?
|
| Skin Ulcer | 1 | 1989 | 19 | 0.090 |
Why?
|
| Polysaccharides | 1 | 2011 | 176 | 0.090 |
Why?
|
| Consensus | 2 | 2020 | 211 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2018 | 880 | 0.080 |
Why?
|
| Proportional Hazards Models | 2 | 2008 | 791 | 0.080 |
Why?
|
| Weight Gain | 1 | 2009 | 135 | 0.080 |
Why?
|
| Memory | 1 | 2010 | 214 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2021 | 2004 | 0.080 |
Why?
|
| Urban Population | 3 | 2014 | 254 | 0.080 |
Why?
|
| Hospitalization | 1 | 2014 | 977 | 0.080 |
Why?
|
| Brain | 1 | 2018 | 2175 | 0.080 |
Why?
|
| Social Class | 1 | 2008 | 127 | 0.080 |
Why?
|
| Awareness | 1 | 2008 | 81 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 2 | 2019 | 201 | 0.080 |
Why?
|
| Employment | 1 | 2008 | 154 | 0.070 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 648 | 0.070 |
Why?
|
| Programming Languages | 1 | 2006 | 16 | 0.070 |
Why?
|
| Smoking | 1 | 2014 | 1449 | 0.070 |
Why?
|
| Chi-Square Distribution | 3 | 2018 | 546 | 0.070 |
Why?
|
| Psychotic Disorders | 1 | 2007 | 157 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 1026 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2008 | 261 | 0.070 |
Why?
|
| Motor Activity | 1 | 2009 | 621 | 0.070 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 106 | 0.060 |
Why?
|
| Somatoform Disorders | 1 | 2004 | 35 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1046 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2008 | 631 | 0.060 |
Why?
|
| Electronic Health Records | 2 | 2018 | 374 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1989 | 529 | 0.060 |
Why?
|
| Suicide | 1 | 2005 | 115 | 0.060 |
Why?
|
| Trauma Centers | 2 | 2016 | 197 | 0.060 |
Why?
|
| Shoes | 1 | 2003 | 8 | 0.060 |
Why?
|
| Societies, Scientific | 1 | 2003 | 18 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 306 | 0.060 |
Why?
|
| Physiology | 1 | 2003 | 12 | 0.060 |
Why?
|
| Awards and Prizes | 1 | 2003 | 27 | 0.060 |
Why?
|
| Weight-Bearing | 1 | 2003 | 53 | 0.060 |
Why?
|
| Motivation | 2 | 2020 | 561 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2003 | 126 | 0.060 |
Why?
|
| Focus Groups | 2 | 2014 | 247 | 0.060 |
Why?
|
| Stress, Mechanical | 1 | 2003 | 208 | 0.060 |
Why?
|
| Pressure | 1 | 2003 | 252 | 0.060 |
Why?
|
| Sex Factors | 2 | 2016 | 1265 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2003 | 248 | 0.050 |
Why?
|
| Control Groups | 1 | 2022 | 10 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2016 | 502 | 0.050 |
Why?
|
| Chelation Therapy | 1 | 2022 | 17 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 189 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2021 | 9 | 0.050 |
Why?
|
| Technology | 1 | 2021 | 24 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 19 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2016 | 1548 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2003 | 249 | 0.050 |
Why?
|
| Aggression | 1 | 2022 | 98 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2022 | 249 | 0.050 |
Why?
|
| Stockings, Compression | 2 | 2011 | 9 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2021 | 58 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 79 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2021 | 39 | 0.050 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 84 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 186 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 110 | 0.050 |
Why?
|
| Executive Function | 1 | 2021 | 106 | 0.050 |
Why?
|
| Expert Testimony | 1 | 2020 | 47 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2016 | 1737 | 0.040 |
Why?
|
| Education, Nonprofessional | 1 | 2018 | 4 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2019 | 98 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 116 | 0.040 |
Why?
|
| Lavandula | 1 | 2018 | 4 | 0.040 |
Why?
|
| Fathers | 1 | 2018 | 16 | 0.040 |
Why?
|
| Confusion | 1 | 2018 | 20 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2011 | 737 | 0.040 |
Why?
|
| California | 1 | 2018 | 99 | 0.040 |
Why?
|
| Indians, North American | 1 | 2018 | 64 | 0.040 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2018 | 73 | 0.040 |
Why?
|
| Bullying | 1 | 2018 | 28 | 0.040 |
Why?
|
| Placebos | 1 | 2018 | 195 | 0.040 |
Why?
|
| Workplace | 1 | 2018 | 75 | 0.040 |
Why?
|
| Syndrome | 1 | 2018 | 255 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 426 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 149 | 0.040 |
Why?
|
| Connectome | 1 | 2018 | 91 | 0.040 |
Why?
|
| Arnica | 1 | 2017 | 2 | 0.040 |
Why?
|
| Calendula | 1 | 2017 | 2 | 0.040 |
Why?
|
| Santalum | 1 | 2017 | 2 | 0.040 |
Why?
|
| Mentha | 1 | 2017 | 4 | 0.040 |
Why?
|
| Social Theory | 1 | 2016 | 2 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 56 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 929 | 0.040 |
Why?
|
| Inpatients | 1 | 2018 | 208 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2018 | 392 | 0.040 |
Why?
|
| Phytotherapy | 1 | 2017 | 53 | 0.040 |
Why?
|
| Transgender Persons | 1 | 2016 | 15 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 281 | 0.040 |
Why?
|
| Kidney | 1 | 2021 | 945 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 503 | 0.040 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 53 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 239 | 0.040 |
Why?
|
| Ambulatory Care | 2 | 2010 | 339 | 0.040 |
Why?
|
| Violence | 1 | 2018 | 275 | 0.040 |
Why?
|
| Refrigeration | 1 | 2016 | 7 | 0.040 |
Why?
|
| Counseling | 1 | 2018 | 279 | 0.040 |
Why?
|
| Food Assistance | 1 | 2016 | 4 | 0.040 |
Why?
|
| Community Health Workers | 1 | 2016 | 32 | 0.040 |
Why?
|
| Text Messaging | 1 | 2016 | 47 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2016 | 204 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2016 | 99 | 0.030 |
Why?
|
| White Matter | 1 | 2018 | 174 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2016 | 219 | 0.030 |
Why?
|
| Self Report | 1 | 2017 | 370 | 0.030 |
Why?
|
| Telephone | 1 | 2016 | 160 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 567 | 0.030 |
Why?
|
| Health Resources | 1 | 2016 | 76 | 0.030 |
Why?
|
| Metatarsal Bones | 1 | 1995 | 3 | 0.030 |
Why?
|
| Suicidal Ideation | 1 | 2016 | 106 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1030 | 0.030 |
Why?
|
| Medicare | 1 | 2016 | 316 | 0.030 |
Why?
|
| Uncertainty | 1 | 2014 | 31 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2014 | 64 | 0.030 |
Why?
|
| Nursing Staff, Hospital | 1 | 2013 | 62 | 0.030 |
Why?
|
| Agriculture | 1 | 2013 | 54 | 0.030 |
Why?
|
| Intensive Care, Neonatal | 1 | 2013 | 38 | 0.030 |
Why?
|
| Pamphlets | 1 | 2012 | 27 | 0.030 |
Why?
|
| Research | 1 | 2014 | 214 | 0.030 |
Why?
|
| Critical Illness | 1 | 2014 | 191 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1753 | 0.030 |
Why?
|
| Peer Group | 1 | 2012 | 104 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 467 | 0.030 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2011 | 12 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2011 | 38 | 0.030 |
Why?
|
| Prescriptions | 1 | 2011 | 28 | 0.030 |
Why?
|
| Nursing Evaluation Research | 1 | 2011 | 46 | 0.030 |
Why?
|
| Gels | 1 | 2011 | 55 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 2222 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2010 | 10 | 0.020 |
Why?
|
| Photoplethysmography | 1 | 2010 | 15 | 0.020 |
Why?
|
| Pediatrics | 1 | 2014 | 341 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2010 | 31 | 0.020 |
Why?
|
| Ankle | 1 | 2010 | 45 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 60 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2010 | 169 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 242 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2009 | 45 | 0.020 |
Why?
|
| Calibration | 1 | 2009 | 73 | 0.020 |
Why?
|
| Infant Care | 1 | 2009 | 31 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2010 | 134 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2009 | 43 | 0.020 |
Why?
|
| Occlusive Dressings | 1 | 1989 | 7 | 0.020 |
Why?
|
| Electrodes | 1 | 2010 | 147 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 413 | 0.020 |
Why?
|
| Energy Intake | 1 | 2009 | 123 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 521 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2010 | 307 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2009 | 196 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 2009 | 157 | 0.020 |
Why?
|
| Lorazepam | 1 | 2007 | 54 | 0.020 |
Why?
|
| Physicians, Family | 1 | 2008 | 82 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 866 | 0.020 |
Why?
|
| Psychomotor Agitation | 1 | 2007 | 63 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 295 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2008 | 147 | 0.020 |
Why?
|
| Body Weight | 1 | 2009 | 554 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2007 | 216 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2009 | 418 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 330 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 96 | 0.020 |
Why?
|
| Insulin | 1 | 2010 | 617 | 0.020 |
Why?
|
| Health Surveys | 1 | 2008 | 488 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2006 | 98 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1745 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2006 | 240 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1989 | 848 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 1425 | 0.020 |
Why?
|
| Aging | 1 | 2009 | 911 | 0.010 |
Why?
|